CD19 and rheumatoid arthritis: Another patient with RA, previously treated with methotrexate, hydroxychloroquine and tocilizumab with persistent low to moderate activity, received a CD19-CD20-directed CAR-T indicated for a relapsed DLBCL attaining RA drug-free remission [41].